SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-249553
Filing Date
2020-09-21
Accepted
2020-09-21 06:09:14
Documents
59
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d80597d6k.htm 6-K 11505
2 EX-99.1 d80597dex991.htm EX-99.1 566007
9 GRAPHIC g80597eytech_logo.jpg GRAPHIC 1387
  Complete submission text file 0001193125-20-249553.txt   6614233

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT eryp-20200630.xml EX-101.INS 2011758
4 XBRL TAXONOMY EXTENSION SCHEMA eryp-20200630.xsd EX-101.SCH 83537
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eryp-20200630_cal.xml EX-101.CAL 50925
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eryp-20200630_def.xml EX-101.DEF 249830
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE eryp-20200630_lab.xml EX-101.LAB 462739
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eryp-20200630_pre.xml EX-101.PRE 354554
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 201185127
SIC: 2836 Biological Products, (No Diagnostic Substances)